CN1435228A - Use of American ginseng spray in treating recurring mouth ulcer - Google Patents
Use of American ginseng spray in treating recurring mouth ulcer Download PDFInfo
- Publication number
- CN1435228A CN1435228A CN 02143665 CN02143665A CN1435228A CN 1435228 A CN1435228 A CN 1435228A CN 02143665 CN02143665 CN 02143665 CN 02143665 A CN02143665 A CN 02143665A CN 1435228 A CN1435228 A CN 1435228A
- Authority
- CN
- China
- Prior art keywords
- radix panacis
- panacis quinquefolii
- spray
- american ginseng
- ulcer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
An American ginseng spray for treating recurrent oral ulcer is disclosed. Its advantages are high curative effect and low cost.
Description
Technical field: this product is used for the treatment of recurrent oral ulceration.Belong to clinical new drug development category.
Technical background: recurrent oral ulceration (being called for short ROU), claim A Fota ulcer again, be meant to have cycle recurrent characteristics, be the disease of feature with the infringement of oral mucosa limitation ulcer.This disease has self limiting, and natural history is 7-14 days.Sickness rate is higher, and the general crowd's prevalence of China is not less than 10%
[1]Its pathogenesis is still very not clear and definite at present.Its pathogenesis is still very not clear and definite at present.Motherland's medical science thinks that this disease is a kind of oral cavity partial reaction of systemic disease, and is evil in close relations with " fire ".Modern medicine think ROU be by damage, stress, the disease that causes of multiple factors such as smoking, endocrine, heredity, immunity, infection, diet
[2]This disease is outbreak repeatedly often, and symptom can gently can weigh, the lighter's mouth numbness discomfort, and weight person's sharp ache has a strong impact on diet and rest unbearably, brings huge misery.Recurrent oral ulceration, integrative therapy does not still have specific medicament at present.Although modern medicine employing hormone and immunomodulator treatment as transfer factor, thymosin etc., though truly have certain curative effect, because use is inconvenient or effect is not good, have limited clinical practice.At present China ROU adopts treatment by Chinese herbs more, as watermelon crystal, XILEI SAN, nourishing yin shengjisan etc., but these medicines not only mouthfeel is poor, absorb also slow.The normal residual black medicated powder of oral mucosa face forms " black mouth ", " black tongue ", make us very awkward, and curative effect is mostly not good, and is invalid substantially after using repeatedly.So make numerous ROU patient feel disappointed.So exploitation has that pain relieving is rapid, ulcer healing is fast, relapse rate is low, more effective, suitable anti-ROU medicine easy to use, characteristics such as the patient accepts is particularly important and urgent.
Radix Panacis Quinquefolii has another name called Radix Panacis Quinquefolii, and English name American ginseng originates in northern US and Canada, belongs to the araliaceae ginseng plant.Its sweet in the mouth, little hardship, cold in nature have and mend and not dry, grow and oiliness characteristics, and the effect of resolving heat and reducing pathogenic fire, YIN nourishing and QI supplementing, promoting the production of body fluid to quench thirst is taken as a kind of senior tonic, uses existing more than 300 year in China.Modern study thinks that except that above-mentioned effect, Radix Panacis Quinquefolii also has effects such as slow down aging, resisting fatigue, anti-hypoxia, enhancing body immunity.Recently studies show that: Radix Panacis Quinquefolii has pain relieving
[3], improve endocrine
[4], antifungal
[5], anti-stress
[6]Etc. function.Wang M
[7]Not only can promote the leukocytic activity of engulfing in one of report Radix Panacis Quinquefolii main component CVT-E002 albumen, reduce inflammation, and can promote the generation of il-1, interleukin-6, tumor necrosis factor-a and NO, thereby stimulate revascularization, fibroblast propagation and collagen synthetic, promote ulcer healing.999 Radix Panacis Quinquefolii buccal tablets are used and shown, but Radix Panacis Quinquefolii through port transmucosal capillary network absorbs directly into blood, absorb rapidly, and are rapid-action, and its effect improves more than three times than the tradition method of swallowing.More than these characteristics provide theoretical foundation for Radix Panacis Quinquefolii spray treatment ROU.Process I and other people is used repeatedly and is shown, said preparation alleviating pain, promotion ulcer healing, reduction rapidly recurs frequency, and therefore test basis of the present invention is reliable.Unfortunately, although Radix Panacis Quinquefolii has above advantage, still there is not the treatment that any Radix Panacis Quinquefolii preparation is used for clinical ROU at present.So the Radix Panacis Quinquefolii spray treatment ROU that development of new is suitable for is not only feasible, and have broad application prospects.
Summary of the invention: this product is made fine powder with exsiccant Radix Panacis Quinquefolii, and packing into has in the plastic bottle of osculum conduit.Plastic bottle soft or hard appropriateness is convenient to squeeze, 1 millimeter of conduit diameter.Squeeze plastic bottle gently, medicated powder is sprayed at ulcer surface, every day 4 times, during serious symptom, can spray for several times.
This product has overcome the deficiency of anti-recurrence stomatocace medicine in the past, makes full use of this preparation advantage and a kind of novel anti stomatocace medicine of developing.Its advantage is as follows:
1. Radix Panacis Quinquefolii medicated powder white is slightly yellow, sweet in the mouth, and mouthfeel is good, can be sprayed at ulcer surface and normal mucosa.The direct inlet port transmucosal of medicine capillary network absorbs soon, and onset is rapid.Its biological effectiveness than tradition swallow the method Senior Three doubly more than.
2. on pathogenesis, this medicine is not only from local analgesia, microcirculation improvement, promotion wound healing, and from the whole body angle by improve stress, leukocyte increasing, enhancing immunity, endocrine regulation function, YIN nourishing make the body recovery normal condition with approach such as fire, reduces the recurrence frequency.
3. this medicament mouthfeel is good, and anti-oral ulcer is effective, and has nourishing function concurrently, and it is extensive to be suitable for the crowd, does not have contraindication substantially, easy to use, easy for patients to accept, clinical having a extensive future.
4. China's Radix Panacis Quinquefolii aboundresources, all there is plantation in many mountain areas, and cost is cheap relatively.This medicament of a large amount of development and use, not only provide a kind of brand-new treatment approach for ROU, and the prosperity that promotes motherland's medical science is also play a part certain, can also promote the mountain area economy development, improve the life of farmers level, thereby can bring huge economic benefit and social benefit.
List of references
[1] Li Bingqi. practical Diseases of the Oral Mucosa. front page. the Sichuan science and technology .1987:93 of publishing house
[2]Semin?Cutan?Med?Surg.1997;16(4):278-83
[3]Yang?JC,Pang?CS,Tsang?SF,Ng?KF.Am?J?Chin?Med.2001;29(1):149-54
[4]Liu?J,Burdette?JE,Xu?H,et?al.J?Agric?Food?Chem.2001;49(5):2472-9
[5]Wang?HX,Ng?TB.Biochem?Biophys?Res?Commun.2000;269(1):203-8
[6] Tan De says, Qiu Haiqiang, Yuan Huinan. new Chinese medicine and clinical pharmacology .2000; 11 (4): 242-43
[7]Wang?M,Guilbert?LJ,Ling?L,et?al.J?Pharmacol.2001;53(11):1515-23
Claims (4)
1. a treatment recurrent oral ulceration pharmaceutical preparation is characterized in that with the Radix Panacis Quinquefolii being main component.
2. according to claims 1 described product, it is characterized in that Radix Panacis Quinquefolii is made Powdered spray.
3. according to claims 1 described product, it is characterized in that directly acting on the canker sore face.
4. the Radix Panacis Quinquefolii spray is in the application of treatment recurrent oral ulceration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02143665 CN1435228A (en) | 2002-01-28 | 2002-09-25 | Use of American ginseng spray in treating recurring mouth ulcer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN02110667 | 2002-01-28 | ||
CN02110667.3 | 2002-01-28 | ||
CN 02143665 CN1435228A (en) | 2002-01-28 | 2002-09-25 | Use of American ginseng spray in treating recurring mouth ulcer |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1435228A true CN1435228A (en) | 2003-08-13 |
Family
ID=27664183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02143665 Pending CN1435228A (en) | 2002-01-28 | 2002-09-25 | Use of American ginseng spray in treating recurring mouth ulcer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1435228A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101095803B (en) * | 2007-07-03 | 2010-05-19 | 广州蓝韵医药研究有限公司 | Chinese traditional medicine preparations for treating mouth ulcer and its preparation method |
JP2016506932A (en) * | 2013-01-30 | 2016-03-07 | ボリス ゴリンステイン | Compositions and methods for treating surface wounds |
-
2002
- 2002-09-25 CN CN 02143665 patent/CN1435228A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101095803B (en) * | 2007-07-03 | 2010-05-19 | 广州蓝韵医药研究有限公司 | Chinese traditional medicine preparations for treating mouth ulcer and its preparation method |
JP2016506932A (en) * | 2013-01-30 | 2016-03-07 | ボリス ゴリンステイン | Compositions and methods for treating surface wounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101549060B (en) | Medicament containing gnetales for treating bronchitis and preparation method thereof | |
CN101732558A (en) | Traditional Chinese medicine granules used for treating chronic pharyngitis | |
CN102091226B (en) | Chinese medicine composition for treating chronic pharyngitis | |
CN101028407A (en) | Oral Chinese-medicinal composition for treating hyperthyroidism | |
CN101041046A (en) | Chinese traditional medicine compound took orally for treating morning diarrhea | |
CN104147388B (en) | Traditional Chinese medicine composition for treating migraine and preparation method thereof | |
CN103784796B (en) | A kind of Chinese medicine preparation for the treatment of simple goiter | |
CN1435228A (en) | Use of American ginseng spray in treating recurring mouth ulcer | |
CN104667188A (en) | Traditional Chinese medicine preparation for treating sphagitis | |
CN105012770A (en) | Health drink and preparation method thereof | |
CN101732500A (en) | Medicine for preventing and treating acute and chronic pharyngitis and sphagitis | |
CN1730065A (en) | Medicament for treating rhinitis | |
CN101062255A (en) | Decoction for treating asthma and so on | |
CN1277573C (en) | Medication for curing ulcerationd of oral cavity | |
CN103127383B (en) | Traditional Chinese medicine for treating children allergic rhinitis | |
CN104623217A (en) | Traditional Chinese medicine preparation for treating asthma and preparation method thereof | |
CN104857414A (en) | Medicine composite for treating chronic simple rhinitis | |
CN1151824C (en) | Oral liquid for treating cough and asthma | |
CN104474455A (en) | Traditional Chinese medicine for treating hyperthyroidism | |
CN108785559A (en) | A kind of drug and preparation method thereof for treating respiratory tract infection | |
CN101732584B (en) | Throat disinhibiting bagged soaking preparation for treating pharyngitis | |
CN114949114B (en) | Agilawood-containing traditional Chinese medicine composition for enhancing immunity as well as preparation method, preparation and application thereof | |
CN107753664A (en) | A kind of Chinese medicine composition for treating allergic rhinitis and preparation method thereof | |
CN105125880A (en) | Traditional Chinese medicine for treating chronic tonsillitis | |
CN1615942A (en) | Rhinitis treating medicinal cream |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |